Paion AG (PA8)
FSX
Closed
Oct 9, 2026
Day's Range
0.046052 wk Range
0.0110Overview - PA8 - Paion AG
Key Statistics
Valuation
Enterprise Value
10.05M
P/E (Trailing)
‪-0.57‬
PEG Ratio
‪0.0042‬
Price / Sales (TTM)
‪0.0098‬
Price / Book
‪-0.10‬
EV / EBITDA
‪2.33‬
Profitability
Gross Margin
‪33.24%‬
Profit Margin
‪94.10%‬
Operating Margin
‪7.82%‬
Return on Assets
‪-1.51%‬
Return on Equity
‪-8.75%‬
Ownership
Shares Outstanding
7.13M
Price stats
50-Day Avg
‪0.0219‬
200-Day Avg
‪0.0145‬
Market Cap - PA8 - Paion AG
Peers - PA8 - Paion AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- PA8FSXPaion AG328.15KMarket Cap+77.83%52-week change-0.58P/E (Trailing)‪94.10%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - PA8 - Paion AG
About
Paion AG is a pharmaceutical company primarily engaged in the development and commercialization of innovative treatments in anesthesia and critical care. The company focuses on creating drugs that address serious medical conditions, aiming to improve patient outcomes and safety. Paion's flagship product, Remimazolam,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
